(Q39462805)

12 September 2017

Improved antitumor efficacy and reduced toxicity of liposomes containing bufadienolides (English)

1 reference

12 September 2017

Kaili Hu

1

1 reference

12 September 2017

Lin Zhu

2

1 reference

12 September 2017

Haiyuan Liang

3

1 reference

12 September 2017

Fuqiang Hu

4

1 reference

12 September 2017

Jianfang Feng

5

1 reference

12 September 2017

1 September 2011

1 reference

Archives of Pharmacal Research

12 September 2017

1 reference

12 September 2017

34

1 reference

12 September 2017

9

1 reference

12 September 2017

1487-1494

1 reference

https://scigraph.springernature.com/pub.10.1007/s12272-011-0910-9

12 September 2017

0 references

cites work

In-vitro antileishmanial and trypanocidal activities of arsonoliposomes and preliminary in-vivo distribution in BALB/c mice

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0910-9

Single bilayer liposomes prepared without sonication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0910-9

In vivo distribution and antitumor activity of heparin-stabilized doxorubicin-loaded liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0910-9

QSAR evaluation of the Ch'an Su and related bufadienolides against the colchicine-resistant primary liver carcinoma cell line PLC/PRF/5(1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0910-9

Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0910-9

Nanocarriers as an emerging platform for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0910-9

Mediating tumor targeting efficiency of nanoparticles through design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0910-9

Liposomal drug delivery systems: an update review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0910-9

Effects of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0910-9

10.1007/S12272-011-0910-9

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference